A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00544960 Information provided by Ascenta Therapeutics

First Received: October 12, 2007 Last Updated: August 24, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: August 12, 2010